The company raised 4,2 MSEK from local business angels in a private funding round.Dec 2021
Microsensor project (Swelife)Chronic pain is the second biggest cost driver in the world in healthcare.
The aim of the project is to develop an innovative In Vivo sensor for identification and localization of deeply located musculoskeletal tissue anomalies (painsources) in patients with chronic pain.
Ultimately our goal is to measure and objectify pain.
Linköping UniversityA qualitative study in elite track and field published
Clinical expansionOur clinical expansion requires more clinicians to strengthen our team and at the same time confirm clinical scalability.
Clinical scalability confirmedIn the end of 2021 we got all the proof for clinical scalability. Three different clinicians with different backgrounds were successfully educated and examined in the Doloradix method.
A system standing on a logic foundation is scalable.